TrialThe American journal of cardiology2007

Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study).

Christie M Ballantyne et al.PubMed ↗Publisher ↗

No numbers read from the abstract.